Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action (Q34503739)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

bariatric surgery

0 references

pharmacotherapy

0 references

type 2 diabetes

0 references

author name string

J Grams

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

W Timothy Garvey

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 June 2015

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Current obesity reports

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

287-302

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Prevalence of childhood and adult obesity in the United States, 2011-2012

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Annual medical spending attributable to obesity: payer-and service-specific estimates

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

(2) Classification and diagnosis of diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Mechanisms linking obesity with cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

The progression of cardiometabolic disease: validation of a new cardiometabolic disease staging system applicable to obesity

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Macrophages, inflammation, and insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Abdominal obesity and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Impaired fasting glucose and impaired glucose tolerance: implications for care

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Long-term non-pharmacological weight loss interventions for adults with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Meta-analysis: pharmacologic treatment of obesity

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Current Treatment Options for the Metabolic Syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Identification and characterization of metabolically benign obesity in humans

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004).

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Effect of weight loss with lifestyle intervention on risk of diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Maintenance of weight loss after lifestyle interventions for overweight and obesity, a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Laparoscopic adjustable gastric banding and progression from impaired fasting glucose to diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Evaluation of current eligibility criteria for bariatric surgery: diabetes prevention and risk factor changes in the Swedish obese subjects (SOS) study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Bariatric surgery and long-term cardiovascular events.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Incidence of type 2 diabetes after bariatric surgery: population-based matched cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Comparison of obese NIDDM and nondiabetic women: short- and long-term weight loss

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Type II diabetic subjects lose less weight than their overweight nondiabetic spouses

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

New options for the treatment of obesity and type 2 diabetes mellitus (narrative review)

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Lifestyle intervention and/or statins for the reduction of C-reactive protein in type 2 diabetes: from the look AHEAD study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Association of an intensive lifestyle intervention with remission of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Role of orlistat in the treatment of obese patients with type 2 diabetes. A 1-year randomized double-blind study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Clinical efficacy of orlistat therapy in overweight and obese patients with insulin-treated type 2 diabetes: A 1-year randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Gastrointestinal surgery: cardiovascular risk reduction and improved long-term survival in patients with obesity and diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

New tools for weight-loss therapy enable a more robust medical model for obesity treatment: rationale for a complications-centric approach

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

American association of clinical endocrinologists and american college of endocrinology consensus conference on obesity: building an evidence base for comprehensive action.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Pharmacological management of obesity: an endocrine Society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, the Obesity Society, and American Soc

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Gastrointestinal surgery for obesity and diabetes: weight loss and control of hyperglycemia.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Bariatric surgery: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Bariatric surgery versus conventional medical therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

The "obese insulin-sensitive" adolescent: importance of adiponectin and lipid partitioning

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Effects of short-term very low-calorie diet on intramyocellular lipid and insulin sensitivity in nondiabetic and type 2 diabetic subjects

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Weight loss reduces liver fat and improves hepatic and skeletal muscle insulin sensitivity in obese adolescents

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Glucose-induced insulin resistance of skeletal-muscle glucose transport and uptake

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Glucosamine-induced insulin resistance in L6 muscle cells

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Role of insulin, adipocyte hormones, and nutrient-sensing pathways in regulating fuel metabolism and energy homeostasis: a nutritional perspective of diabetes, obesity, and cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Insulin treatment reverses the postreceptor defect in adipocyte 3-O-methylglucose transport in type II diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Effect of sulfonylurea treatment on in vivo insulin secretion and action in patients with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Hyperglycemia decreases glucose uptake in type I diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Effects of bariatric surgery on glucose homeostasis and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Predictors of remission of type 2 diabetes mellitus after laparoscopic gastric banding and bypass.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Analysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Enteral Enhancement of Glucose Disposition by Both Insulin-Dependent and Insulin-Independent Processes: A Physiological Role of Glucagon-Like Peptide I

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Diabetes remission after bariatric surgery: is it just the incretins?

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Sleeve gastrectomy and type 2 diabetes mellitus: a systematic review

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Early enhancements of hepatic and later of peripheral insulin sensitivity combined with increased postprandial insulin secretion contribute to improved glycemic control after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Mechanism of metabolic advantages after bariatric surgery: it's all gastrointestinal factors versus it's all food restriction.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Mechanisms of type 2 diabetes resolution after Roux-en-Y gastric bypass.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery?

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Postprandial diabetic glucose tolerance is normalized by gastric bypass feeding as opposed to gastric feeding and is associated with exaggerated GLP-1 secretion: a case report

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Bile acids as regulatory molecules

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Postprandial plasma bile acid responses in normal weight and obese subjects

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Bile acid metabolism and the pathogenesis of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Serum bile acids are higher in humans with prior gastric bypass: potential contribution to improved glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Roux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Role of bile acids and bile acid receptors in metabolic regulation

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Bile-induced secretion of glucagon-like peptide-1: pathophysiological implications in type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Intestinal adaptation after ileal interposition surgery increases bile acid recycling and protects against obesity-related comorbidities

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

A surgical model in male obese rats uncovers protective effects of bile acids post-bariatric surgery.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

FXR is a molecular target for the effects of vertical sleeve gastrectomy

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Microbial ecology: human gut microbes associated with obesity

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

An obesity-associated gut microbiome with increased capacity for energy harvest

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Gut microflora as a target for energy and metabolic homeostasis

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

A core gut microbiome in obese and lean twins

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Metabolic surgery: an evolution through bariatric animal models

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Gastric bypass reduces fat intake and preference.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

The importance of the gut microbiota after bariatric surgery

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Human gut microbiota in obesity and after gastric bypass

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

The gut microbiota as an environmental factor that regulates fat storage

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Metagenomic analysis of the human distal gut microbiome

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Metabolic endotoxemia initiates obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Microbiota and SCFA in lean and overweight healthy subjects

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Gut microbiota from twins discordant for obesity modulate metabolism in mice

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Human adipose tissue macrophages: m1 and m2 cell surface markers in subcutaneous and omental depots and after weight loss

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Bariatric surgery, adipose tissue and gut microbiota

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Weight loss after gastric bypass surgery in human obesity remodels promoter methylation

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Altered promoter methylation of PDK4, IL1 B, IL6, and TNF after Roux-en Y gastric bypass

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Role of microRNAs in obesity and the metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass.

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Predictive factors of type 2 diabetes mellitus remission following bariatric surgery: a meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Insulin Resistance and Atherosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity

1 reference

https://api.crossref.org/works/10.1007%2FS13679-015-0155-X

21 January 2018

Obesity and diabetes: the impact of bariatric surgery on type-2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UK Prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients, UKPDS Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bile Routing Modification Reproduces Key Features of Gastric Bypass in Rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting the circulating microRNA signature of obesity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The benefits of modest weight loss in type II diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose and insulin co-regulate the glucose transport system in primary cultured adipocytes. A new mechanism of insulin resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alterations of hormonally active fibroblast growth factors after Roux-en-Y gastric bypass surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term non-pharmacological weight loss interventions for adults with prediabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/26627223

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S13679-015-0155-X

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34503739&oldid=2196719417"